CADL
Candel Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.96 / 10
Netural
Sentiment is neutral with a money-flow score of 7.71/10, reflecting strong fund inflows; however, the overall, block, small, medium, large, and extra-large flow trends are all negative, hinting at underlying selling pressure. Analyst consensus is overwhelmingly bullish (100% Buy ratings from one analyst), yet the historical weighted rating is only 2.20, suggesting limited conviction. This blend of positive flow and bullish analyst views is tempered by negative price action, resulting in a neutral-to-cautious outlook.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-08
InstitutionStephens & Co.
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of CADL?
- CADL holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.96/10 (Netural).
